rs201780665
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_181426.2(CCDC39):c.1795C>T(p.Arg599Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000875 in 1,611,134 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. R599R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_181426.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCDC39 | NM_181426.2 | c.1795C>T | p.Arg599Ter | stop_gained | 13/20 | ENST00000476379.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCDC39 | ENST00000476379.6 | c.1795C>T | p.Arg599Ter | stop_gained | 13/20 | 2 | NM_181426.2 | P2 |
Frequencies
GnomAD3 genomes ? AF: 0.0000461 AC: 7AN: 151956Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000765 AC: 19AN: 248382Hom.: 0 AF XY: 0.0000594 AC XY: 8AN XY: 134776
GnomAD4 exome AF: 0.0000918 AC: 134AN: 1459060Hom.: 0 Cov.: 30 AF XY: 0.0000840 AC XY: 61AN XY: 725796
GnomAD4 genome ? AF: 0.0000460 AC: 7AN: 152074Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74338
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 03, 2024 | This sequence change creates a premature translational stop signal (p.Arg599*) in the CCDC39 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CCDC39 are known to be pathogenic (PMID: 21131972, 23255504). This variant is present in population databases (rs201780665, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with primary ciliary dyskinesia (PMID: 23255504, 24498942). ClinVar contains an entry for this variant (Variation ID: 455014). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2021 | The p.R599* pathogenic mutation (also known as c.1795C>T), located in coding exon 13 of the CCDC39 gene, results from a C to T substitution at nucleotide position 1795. This changes the amino acid from an arginine to a stop codon within coding exon 13. This mutation has been reported in one homozgyous and two compound heterozygous individuals with primary ciliary dyskiensia (Antony D et al. Hum Mutat, 2013 Mar;34:462-72; Davis SD et al. Am J Respir Crit Care Med, 2019 01;199:190-198). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Jan 21, 2022 | - - |
Primary ciliary dyskinesia 14 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Diagnostics Laboratory, M Health Fairview: University of Minnesota | Nov 24, 2020 | - - |
Ellis-van Creveld syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Rare Disease Group, Clinical Genetics, Karolinska Institutet | May 01, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at